ClinicalThought
View More
Factor replacement therapies and newer nonfactor agents offer the ability to tailor therapy for individual patients with hemophilia A. Additional therapies in late-stage development are poised to further alter the treatment landscape. Read an expert’s thoughts on how these new therapies might fit into the existing treatment paradigms in hemophilia A.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.